Key Takeaways
- • Baillie Gifford's US Growth Trust offered activist investor Saba Capital a tender offer at 99.75% of net asset value open to all shareholders, which Saba rejected despite owning approximately 29% of the trust.
- • Saba Capital, led by activist investor Boaz Weinstein, is now pursuing a director installation strategy, seeking to place three directors on the trust's board following the failed buyout offer.
- • The rejected tender offer represents a strategic attempt by Baillie Gifford to address shareholder activism and potential governance changes through a broad-based repurchase mechanism rather than direct negotiation with the activist holder.
Summary
Baillie Gifford's US Growth Trust has disclosed that it made a formal offer to acquire shares from Saba Capital at 99.75% of net asset value, structured as a tender offer available to all shareholders. The proposal was rejected by Saba, which holds approximately 29% of the trust's equity. This rejected offer provides context for the subsequent escalation of the dispute between the investment firm and the activist investor.
Boaz Weinstein's Saba Capital, which has emerged as a significant shareholder in the trust, is now pursuing board representation as its primary avenue for influence. The activist investor is seeking to install three directors on the trust's board, signaling an intent to drive strategic or operational changes at the portfolio company level. The rejection of Baillie Gifford's tender offer suggests Saba views board seats as more valuable than a buyout at the offered price, indicating the activist believes the trust is undervalued or mismanaged.
The 99.75% NAV tender offer from Baillie Gifford represents a standard defensive mechanism in closed-end fund activism, designed to provide exit liquidity at near-asset value while avoiding direct control negotiations with a large shareholder. However, Saba's rejection indicates the activist investor's objectives extend beyond yield or capital appreciation—suggesting concerns about portfolio allocation, fee structure, or investment strategy that would be addressable only through board-level influence and control.
Boaz Weinstein's Saba Capital, which has emerged as a significant shareholder in the trust, is now pursuing board representation as its primary avenue for influence. The activist investor is seeking to install three directors on the trust's board, signaling an intent to drive strategic or operational changes at the portfolio company level. The rejection of Baillie Gifford's tender offer suggests Saba views board seats as more valuable than a buyout at the offered price, indicating the activist believes the trust is undervalued or mismanaged.
The 99.75% NAV tender offer from Baillie Gifford represents a standard defensive mechanism in closed-end fund activism, designed to provide exit liquidity at near-asset value while avoiding direct control negotiations with a large shareholder. However, Saba's rejection indicates the activist investor's objectives extend beyond yield or capital appreciation—suggesting concerns about portfolio allocation, fee structure, or investment strategy that would be addressable only through board-level influence and control.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.